Renal Thrombotic Microangiopathy in Concurrent COVID-19 Vaccination and Infection

We report on the development of nephrotic proteinuria and microhematuria, with histological features of renal thrombotic microangiopathy (TMA), following the first dose of BNT162b2 COVID-19 vaccine (Pfizer-BioNTech) and COVID-19 diagnosis. A 35-year-old previously healthy man was admitted at our hos...

Descripción completa

Detalles Bibliográficos
Autores principales: De Fabritiis, Marco, Angelini, Maria Laura, Fabbrizio, Benedetta, Cenacchi, Giovanna, Americo, Claudio, Cristino, Stefania, Lifrieri, Maria Francesca, Cappuccilli, Maria, Spazzoli, Alessandra, Zambianchi, Loretta, Mosconi, Giovanni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8400339/
https://www.ncbi.nlm.nih.gov/pubmed/34451509
http://dx.doi.org/10.3390/pathogens10081045

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8400339/
https://www.ncbi.nlm.nih.gov/pubmed/34451509
http://dx.doi.org/10.3390/pathogens10081045

Ejemplares similares